Cargando…
P4HTM: A Novel Downstream Target of GATA3 in Breast Cancer
Breast cancer continues to be a major cause of death among women. The GATA3 gene is often overexpressed in breast cancer and is widely used to support a diagnosis. However, lower expression of GATA3 has been linked to poorer prognosis along with frequent gene mutations. Therefore, the role of GATA3...
Autores principales: | DiDonna, Sarah C., Nagornyuk, Aerica, Adhikari, Neeta, Takada, Mamoru, Takaku, Motoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002838/ https://www.ncbi.nlm.nih.gov/pubmed/36909571 http://dx.doi.org/10.21203/rs.3.rs-2622989/v1 |
Ejemplares similares
-
Genomic transcription factor binding site selection is edited by the chromatin remodeling factor CHD4
por: Saotome, Mika, et al.
Publicado: (2023) -
Htm1p: getting a “sugar-handle” on misfolded proteins
por: Sedwick, Caitlin
Publicado: (2009) -
GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer
por: Bai, Feng, et al.
Publicado: (2021) -
GATA3 Truncation Mutants Alter EMT Related Gene Expression via Partial Motif Recognition in Luminal Breast Cancer Cells
por: Saotome, Mika, et al.
Publicado: (2022) -
Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover
por: Adomas, Aleksandra B, et al.
Publicado: (2014)